Alibaba Health Information Technology Limited (ALBHF) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Alibaba Health Information Technology Limited stock forecast from 0 analysts, the average analyst target price for Alibaba Health Information Technology Limited is not available over the next 12 months. Alibaba Health Information Technology Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Alibaba Health Information Technology Limited is Neutral, which is based on 7 positive signals and 6 negative signals. At the last closing, Alibaba Health Information Technology Limited’s stock price was USD 0.75. Alibaba Health Information Technology Limited’s stock price has changed by +16.92% over the past week, +51.78% over the past month and +59.89% over the last year.
No recent analyst target price found for Alibaba Health Information Technology Limited
No recent average analyst rating found for Alibaba Health Information Technology Limited
Company Overview Alibaba Health Information Technology Limited
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, health food, adult and family planning products, healthcare and skincare products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, appointment-booking, vaccination, dental care, mental care, optometry, and nursing services, as well as traditional Chinese medicines. The company provides is products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Ele.me, AMap, DingTalk, Freshippo, and Quark. In addition, it engages in the digital tracking business; provision of network hospital, software technical services, healthcare related internet information and technical services; operation of internet hospitals, as well as Doctor U, an intelligent and one-stop platform for doctor and patient education; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong. Read Less
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription...Read More
Frequently Asked Questions About Alibaba Health Information Technology Limited (ALBHF) Stock
Stock Target Advisor's fundamental analysis for Alibaba Health Information Technology Limited's stock is Neutral.
Unfortunately we do not have enough data on ALBHF's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ALBHF's stock to indicate what its average analyst target is.
ALBHF stock's Price/Earning ratio is 74.80.
Our analysis grades ALBHF stock's Price / Earning ratio at F. This means that ALBHF stock's Price/Earning ratio is above 83% of the stocks in the Pharmaceutical Retailers sector in the OTC exchange.
Based on this ALBHF may be a overvalued for its sector.
The last closing price of ALBHF's stock was USD 0.75.
The most recent market capitalization for ALBHF is USD 12.04B.
Unfortunately we do not have enough analyst data on ALBHF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Alibaba Health Information Technology Limited's stock.
As per our most recent records Alibaba Health Information Technology Limited has 1,422 Employees.
Alibaba Health Information Technology Limited's registered address is Tower One, Causeway Bay, Hong Kong.
You can get more information about it from Alibaba Health Information Technology Limited's website at https://www.alihealth.cn.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Alibaba Health Information Technology Limited (ALBHF) Stock
Stock Target Advisor's fundamental analysis for Alibaba Health Information Technology Limited's stock is Neutral.
Unfortunately we do not have enough data on ALBHF's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ALBHF's stock to indicate what its average analyst target is.
ALBHF stock's Price/Earning ratio is 74.80.
Our analysis grades ALBHF stock's Price / Earning ratio at F. This means that ALBHF stock's Price/Earning ratio is above 83% of the stocks in the Pharmaceutical Retailers sector in the OTC exchange.
Based on this ALBHF may be a overvalued for its sector.
The last closing price of ALBHF's stock was USD 0.75.
The most recent market capitalization for ALBHF is USD 12.04B.
Unfortunately we do not have enough analyst data on ALBHF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Alibaba Health Information Technology Limited's stock.
As per our most recent records Alibaba Health Information Technology Limited has 1,422 Employees.
Alibaba Health Information Technology Limited's registered address is Tower One, Causeway Bay, Hong Kong.
You can get more information about it from Alibaba Health Information Technology Limited's website at https://www.alihealth.cn.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ALBHF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
